These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15784331)

  • 21. Electrically enhanced solute permeation across poly(ethylene glycol)-crosslinked poly(methyl vinyl ether-co-maleic acid) hydrogels: effect of hydrogel crosslink density and ionic conductivity.
    Garland MJ; Singh TR; Woolfson AD; Donnelly RF
    Int J Pharm; 2011 Mar; 406(1-2):91-8. PubMed ID: 21236323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral administration of paclitaxel with pegylated poly(anhydride) nanoparticles: permeability and pharmacokinetic study.
    Zabaleta V; Ponchel G; Salman H; Agüeros M; Vauthier C; Irache JM
    Eur J Pharm Biopharm; 2012 Aug; 81(3):514-23. PubMed ID: 22516136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Poly(methyl vinyl ether-co-maleic acid) for enhancement of solubility, oral bioavailability and anti-osteoporotic effects of raloxifene hydrochloride.
    Varshosaz J; Minaiyan M; Dayyani L
    Eur J Pharm Sci; 2018 Jan; 112():195-206. PubMed ID: 29196024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of bioadhesive capacity and immunoadjuvant properties of vitamin B(12)-Gantrez nanoparticles.
    Salman HH; Gamazo C; de Smidt PC; Russell-Jones G; Irache JM
    Pharm Res; 2008 Dec; 25(12):2859-68. PubMed ID: 18679774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclodextrin-grafted poly(anhydride) nanoparticles for oral glibenclamide administration. In vivo evaluation using C. elegans.
    Lucio D; Martínez-Ohárriz MC; Gu Z; He Y; Aranaz P; Vizmanos JL; Irache JM
    Int J Pharm; 2018 Aug; 547(1-2):97-105. PubMed ID: 29842888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-PEG antibodies alter the mobility and biodistribution of densely PEGylated nanoparticles in mucus.
    Henry CE; Wang YY; Yang Q; Hoang T; Chattopadhyay S; Hoen T; Ensign LM; Nunn KL; Schroeder H; McCallen J; Moench T; Cone R; Roffler SR; Lai SK
    Acta Biomater; 2016 Oct; 43():61-70. PubMed ID: 27424083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of NMR spectroscopy to the characterization of PEG-stabilized lipid nanoparticles.
    Garcia-Fuentes M; Torres D; Martín-Pastor M; Alonso MJ
    Langmuir; 2004 Sep; 20(20):8839-45. PubMed ID: 15379515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of reaction medium during synthesis of Gantrez AN 119 nanoparticles for oral vaccination.
    Vandamme K; Melkebeek V; Cox E; Deforce D; Lenoir J; Adriaens E; Vervaet C; Remon JP
    Eur J Pharm Biopharm; 2010 Feb; 74(2):202-8. PubMed ID: 19819332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PEGylated Nanoparticles based on a polyaspartamide. preparation, physico-chemical characterization, and intracellular uptake.
    Craparo EF; Cavallaro G; Bondì ML; Mandracchia D; Giammona G
    Biomacromolecules; 2006 Nov; 7(11):3083-92. PubMed ID: 17096535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
    Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
    Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Self-aggregated pegylated poly (trimethylene carbonate) nanoparticles decorated with c(RGDyK) peptide for targeted paclitaxel delivery to integrin-rich tumors.
    Jiang X; Sha X; Xin H; Chen L; Gao X; Wang X; Law K; Gu J; Chen Y; Jiang Y; Ren X; Ren Q; Fang X
    Biomaterials; 2011 Dec; 32(35):9457-69. PubMed ID: 21911250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation and evaluation of Baicalin-loaded cationic solid lipid nanoparticles conjugated with OX26 for improved delivery across the BBB.
    Liu Z; Zhao H; Shu L; Zhang Y; Okeke C; Zhang L; Li J; Li N
    Drug Dev Ind Pharm; 2015 Mar; 41(3):353-61. PubMed ID: 25784073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Salmonella-like bioadhesive nanoparticles.
    Salman HH; Gamazo C; Campanero MA; Irache JM
    J Control Release; 2005 Aug; 106(1-2):1-13. PubMed ID: 15970347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Poly(ethylene oxide)-modified poly(epsilon-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer.
    Shenoy DB; Amiji MM
    Int J Pharm; 2005 Apr; 293(1-2):261-70. PubMed ID: 15778064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Roles of acid/base nature and molecular weight in drug release from matrices of gelfoam and monoisopropyl ester of poly(vinyl methyl ether-maleic anhydride).
    Hämäläinen KM; Määttä E; Piirainen H; Marianne Sarkola ; Väisänen A; Ranta VP; Urtti A
    J Control Release; 1998 Dec; 56(1-3):273-83. PubMed ID: 9801450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of thiolated, PEGylated and POZylated silica nanoparticles and evaluation of their retention on rat intestinal mucosa in vitro.
    Ways TMM; Lau WM; Ng KW; Khutoryanskiy VV
    Eur J Pharm Sci; 2018 Sep; 122():230-238. PubMed ID: 29969667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of surface-coated liposomes for oral delivery of peptide: effects of coating the liposome's surface on the GI transit of insulin.
    Iwanaga K; Ono S; Narioka K; Kakemi M; Morimoto K; Yamashita S; Namba Y; Oku N
    J Pharm Sci; 1999 Feb; 88(2):248-52. PubMed ID: 9950646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of polymer architecture on surface properties, plasma protein adsorption, and cellular interactions of pegylated nanoparticles.
    Sant S; Poulin S; Hildgen P
    J Biomed Mater Res A; 2008 Dec; 87(4):885-95. PubMed ID: 18228249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of PEG on polymeric particles surface, a key step in drug carrier translation.
    Rabanel JM; Hildgen P; Banquy X
    J Control Release; 2014 Jul; 185():71-87. PubMed ID: 24768790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanoparticles with specific bioadhesive properties to circumvent the pre-systemic degradation of fluorinated pyrimidines.
    Arbós P; Campanero MA; Arangoa MA; Irache JM
    J Control Release; 2004 Apr; 96(1):55-65. PubMed ID: 15063029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.